Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SPXCY | MTZ |
|---|---|---|
| Price | $32.46 | $219.40 |
| Change today | ▼ 1.37% | ▲ 1.61% |
| Market cap | $17.62B | $17.62B |
| Return, 3 months | -13.3% | -38.9% |
| Return, year to date | +24.9% | +0.9% |
| Return, 1 year | +17.8% | +1.2% |
| P/E (TTM) | 32.1 | 34.9 |
| P/B | 9.4 | 5.1 |
| P/E percentile vs own 5y | – | 45th |
| Dividend yield | 2.05% | – |
| Revenue growth (YoY, latest qtr) | – | +23.4% |
| Net profit growth (YoY) | – | +61.7% |
| Gross margin | – | 12.9% |
| Operating margin | – | 5.1% |
| Net margin | – | 3.1% |
| Return on equity | – | 15.4% |
| Analyst target vs. price | – | +93.8% |
| Analyst buy share | – | 100% |
| RSI (14) | 23 | 43 |
| 30-day volatility | 29.4% | 47.5% |
| Max drawdown, 1 year | -19.1% | -53.4% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
